Covalon Technologies (OTCMKTS:CVALF – Get Free Report) announced its earnings results on Thursday. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.02, Zacks reports. Covalon Technologies had a return on equity of 3.31% and a net margin of 3.08%.The firm had revenue of $6.27 million for the quarter, compared to the consensus estimate of $6.70 million.
Covalon Technologies Price Performance
Shares of CVALF stock opened at $1.46 on Friday. Covalon Technologies has a 1-year low of $1.16 and a 1-year high of $2.14. The stock’s fifty day moving average price is $1.38 and its 200 day moving average price is $1.33. The company has a market cap of $40.33 million, a price-to-earnings ratio of 73.04 and a beta of 0.59.
About Covalon Technologies
Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.
The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.
Further Reading
- Five stocks we like better than Covalon Technologies
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
- Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half
- Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
- Intuit’s Great SaaS Reset: Fired By AI
Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
